Urology
Home Urology
November 2016 Briefing – Urology
Here are what the editors at HealthDay consider to be the most important developments in Urology for November 2016. This roundup includes the latest...
Many Low-Risk Prostate Cancer Cases Upgraded at Prostatectomy
Upgrading, up staging linked to age >60, PSA >5.0 ng/ml, and >25 percent positive cores
Prognosis Good With Negative Biopsy in Active Surveillance
Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes
U.S. Health Care System Is One of the Least Efficient Worldwide
America ranked 50 out of 55 countries in 2014, according to a Bloomberg index
Research & Development Investments Do Not Explain Drug Price Variation
No association seen between estimated R&D investments and treatment costs based on list prices at launch or net prices after one year
Transcutaneous Tibial Nerve Stimulation Device Beneficial in Overactive Bladder
Wearable, smartphone-controlled, rechargeable device effective for reducing voiding frequency; is safe in overactive bladder
Gender Gap Persists in Starting Salary for Physicians
Gender differences in preferences for control over work-life balance do not account for gap in salary
Caution in Social Media Age: Self-Promotion Can Backfire
Too much self-promotion can offend others, researchers note
Studies Used for FDA Approval of Device Changes Often Low Quality
And, efficacy of drugs granted accelerated approval often confirmed only years after approval
Risk of Injuries Up Around Period of Cancer Diagnosis
Increased risk of iatrogenic injuries, non-iatrogenic injuries before and after diagnosis of cancer
